• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌放射性碘治疗后颈动脉破裂

Carotid artery rupture following radioiodine therapy for differentiated thyroid carcinoma.

作者信息

Cunha Danilo da Silva, Simões Maria Izilda Previato, Viviani Dionísio Nepomuceno, Boldrini Domingos, Rocha Euclides Timóteo da, Morini Sandra Regina, Moriguchi Sonia Marta

机构信息

Department Nuclear Medicine, Hospital de Câncer de Barretos, Barretos, SP, Brazil.

出版信息

Arq Bras Endocrinol Metabol. 2011 Aug;55(6):419-25. doi: 10.1590/s0004-27302011000600009.

DOI:10.1590/s0004-27302011000600009
PMID:22011859
Abstract

INTRODUCTION

Radioiodine therapy for patients with differentiated thyroid cancer aims at reducing tumor recurrence by eradicating residual macro- and microscopic foci. Side effects are generally rare, tenuous and transient, with little clinical significance.

OBJECTIVE

To report a rare case of differentiated thyroid carcinoma presenting a large expansive solid mass at the base of the skull, with invasion of the left masticatory muscle and adjacent subcutaneous tissue, and without invasion of the carotid space, which evolved to carotid artery rupture following radioiodine therapy.

DISCUSSION

Side effects are uncommon after radioiodine therapy and when present, have mild intensity. Serious adverse events are very rare, especially those arising from structures not directly invaded by metastatic tissue with radioiodine uptake, as occurred in this case. This occurrence serves to raise awareness of the need for increased care when using radioiodine therapy on high-avidity masses located close to important structures.

摘要

引言

分化型甲状腺癌患者的放射性碘治疗旨在通过根除残留的大体和微小病灶来降低肿瘤复发率。副作用通常罕见、轻微且短暂,临床意义不大。

目的

报告一例罕见的分化型甲状腺癌病例,该病例在颅底出现一个巨大的实性肿块,侵犯左侧咀嚼肌及相邻皮下组织,但未侵犯颈动脉间隙,在放射性碘治疗后演变为颈动脉破裂。

讨论

放射性碘治疗后副作用并不常见,即便出现,程度也较轻。严重不良事件非常罕见,尤其是像本例这样由未被放射性碘摄取的转移组织直接侵犯的结构所引发的事件。这一病例提醒人们,对于靠近重要结构的高摄取肿块进行放射性碘治疗时,需提高警惕。

相似文献

1
Carotid artery rupture following radioiodine therapy for differentiated thyroid carcinoma.分化型甲状腺癌放射性碘治疗后颈动脉破裂
Arq Bras Endocrinol Metabol. 2011 Aug;55(6):419-25. doi: 10.1590/s0004-27302011000600009.
2
Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer.
Ann Nucl Med. 2006 Aug;20(7):499-502. doi: 10.1007/BF02987260.
3
Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer.放射性碘对儿童分化型甲状腺癌的早期和晚期不良反应
Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26595. Epub 2017 Apr 24.
4
Gonadal damage due to radioactive iodine (I131) treatment for thyroid carcinoma.放射性碘(I131)治疗甲状腺癌导致的性腺损伤。
Postgrad Med J. 1985 Apr;61(714):361-2. doi: 10.1136/pgmj.61.714.361.
5
Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer.放射性碘定量治疗分化型甲状腺癌
Q J Nucl Med. 1999 Dec;43(4):313-23.
6
Radioiodine therapy for differentiated thyroid carcinoma.分化型甲状腺癌的放射性碘治疗
Am J Surg. 1988 Dec;156(6):519-21. doi: 10.1016/s0002-9610(88)80543-9.
7
Unusual case of well-differentiated papillary thyroid carcinoma lacking thyroglobulin expression while still concentrating radioiodine.分化良好的甲状腺乳头状癌罕见病例,缺乏甲状腺球蛋白表达但仍摄取放射性碘。
Br J Radiol. 2006 Sep;79(945):e84-7. doi: 10.1259/bjr/62250180.
8
[The basis for radioiodine therapy in differentiated thyroid cancer].[分化型甲状腺癌放射性碘治疗的基础]
Ther Umsch. 1999 Jul;56(7):403-7. doi: 10.1024/0040-5930.56.7.403.
9
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.手术、放射性碘及外照射放疗对分化型甲状腺癌患者临床结局的影响。
Cancer. 1998 Jan 15;82(2):375-88.
10
Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age.107例分化型甲状腺癌伴初始骨转移患者放射性碘治疗后的结局:副作用及年龄的影响
Eur J Nucl Med. 2001 Feb;28(2):203-8. doi: 10.1007/s002590000420.

引用本文的文献

1
Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis.p16和RASSF1A基因启动子甲基化可能与甲状腺乳头状癌风险相关:一项荟萃分析。
Exp Ther Med. 2015 Oct;10(4):1549-1555. doi: 10.3892/etm.2015.2656. Epub 2015 Jul 24.